Clinical Trial Update: Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating irreversible electroporation in combination with pembrolizumab in locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Pancreatic Cancer, Locally Advanced Pancreatic Cancer | Phase 1 | Status: COMPLETED